Skip to main content
Figure 1 | Arthritis Res Ther

Figure 1

From: Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept

Figure 1

Serum COMP (S-COMP) at baseline and after 3 and 6 months in rheumatoid arthritis patients treated with etanercept. Serum COMP was lower than at baseline after 3 months (P < 0.005). The levels remained low after 6 months, although not significantly lower than at baseline (P = 0.07). See text for details. COMP = cartilage oligomeric matrix protein (thrombospondin-5).

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us